Stock Institutional Ownership and Shareholders

SecurityPTN / Palatin Technologies, Inc. (696077403)
President and CEOSPANA CARL
Institutional Owners47
Institutional Shares17,754,822
Outstanding Shares201,360,736 (as of 2017-09-30)
Institutional Value$ 10,913,000 USD

Palatin Technologies, Inc. (AMEX:PTN) has 47 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17,754,822 shares. Largest shareholders include Vanguard Group Inc, QVT Financial LP, Alyeska Investment Group, L.P., Alyeska Investment Group, L.P., BlackRock Inc., Geode Capital Management, Llc, California Public Employees Retirement System, Virtu Financial LLC, Acadian Asset Management Llc, and Northern Trust Corp.



Palatin Technologies, Inc. (AMEX:PTN) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2017-11-14 13F-HR HighTower Advisors, LLC 12,000 17,000 41.67 5 11 120.00
2017-11-14 13F-HR COMPTON CAPITAL MANAGEMENT INC /RI 13,000 13,000 0.00 6 9 50.00
2017-11-13 13F-HR US BANCORP \DE\ 159,740 159,740 0.00 69 106 53.62
2017-10-10 13F-HR Baystate Wealth Management LLC 13,233 13,233 0.00 6 11 83.33
2017-11-14 13F-HR Carnegie Capital Asset Management, LLC 30,000 30,000 0.00 13 23 76.92
2017-11-14 13F-HR MILLENNIUM MANAGEMENT LLC 0 24,100 0 16
2017-11-20 13F-HR Crestwood Advisors LLC 25,000 25,000 0.00 10 17 70.00
2017-10-25 13F-HR Rehmann Capital Advisory Group 12,000 12,000 0.00 5 8 60.00
2017-11-07 13F-HR Russell Investments Group, Ltd. 225,246 149
2017-11-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 839,777 839,777 0.00 361 556 54.02
2017-11-16 13F-HR SALEM INVESTMENT COUNSELORS INC 150 0 -100.00 0 0
2017-11-14 13F-HR SABBY MANAGEMENT, LLC 553,740 0 -100.00 238 0 -100.00
2017-08-14 13F-HR Squarepoint Ops LLC 170,200 0 -100.00 56 0 -100.00
2017-11-14 13F-HR TWO SIGMA SECURITIES, LLC 22,854 66,547 191.18 10 44 340.00
2017-11-13 13F-HR Bb&t Investment Services, Inc. 20 20 0.00 0 0
2017-11-14 13F-HR Alyeska Investment Group, L.P. Call 1,538,462 1,538,462 0.00 662 1,020 54.08
2017-11-14 13F-HR MML INVESTORS SERVICES, LLC 13,433 0 -100.00 6 0 -100.00
2017-11-14 13F-HR BANK OF AMERICA CORP /DE/ 1,953 1,953 0.00 1 1 0.00
2017-11-14 13F-HR STATE STREET CORP 17,409 17,409 0.00 7 12 71.43
2017-11-14 13F-HR VANGUARD GROUP INC 4,064,031 6,119,473 50.58 1,748 4,057 132.09
2017-11-14 13F-HR DEUTSCHE BANK AG\ 51 51 0.00 0 0
2017-11-14 13F-HR BlackRock Inc. 1,002,818 1,234,850 23.14 431 819 90.02
2017-11-14 13F-HR LPL Financial LLC 25,005 15,005 -39.99 11 10 -9.09
2017-11-06 13F-HR Advisor Group, Inc. 1,765 1,765 0.00 1 1 0.00
2017-11-13 13F-HR NORTHERN TRUST CORP 123,051 326,915 165.67 53 216 307.55
2017-11-14 13F-HR Alyeska Investment Group, L.P. 3,324,871 2,385,321 -28.26 1,430 1,581 10.56
2017-11-16 13F-HR Cetera Investment Advisers 16,155 0 -100.00 7 0 -100.00
2017-11-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 1,040 1,040 0.00 0 1
2017-11-16 13F-HR Cetera Advisors LLC 16,155 0 -100.00 7 0 -100.00
2017-11-07 13F-HR Commonwealth Equity Services, Inc 13,250 17,450 31.70 5 11 120.00
2017-11-13 13F-HR CAPTRUST FINANCIAL ADVISORS 11,750 0 -100.00 5 0 -100.00
2017-11-06 13F-HR SEI INVESTMENTS CO 17,000 17,000 0.00 7 11 57.14
2017-11-13 13F-HR National Asset Management, Inc. 15,000 0 -100.00 7 0 -100.00
2017-11-14 13F-HR UBS Group AG 2,678 17,811 565.09 1 12 1,100.00
2017-11-14 13F-HR Baker Brothers Advisors LP 2,050,000 0 -100.00 882 0 -100.00
2017-11-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 488,202 488,202 0.00 210 324 54.29
2017-11-01 13F-HR WealthTrust Axiom LLC 27,310 26,860 -1.65 11 17 54.55
2017-10-18 13F-HR WealthTrust-Arizona, LLC 200 200 0.00 0 0
2017-10-31 13F-HR PALISADE CAPITAL MANAGEMENT LLC/NJ 19,010 19,010 0.00 8 13 62.50
2017-11-14 13F-HR QVT Financial LP 4,296,847 4,296,847 0.00 1,293 1,994 54.22
2017-11-27 13F-HR/A-1 SPHERA FUNDS MANAGEMENT LTD. 470,983 0 -100.00 203 0 -100.00
2017-10-26 13F-HR Raymond James Financial Services Advisors, Inc. 15,805 14,805 -6.33 7 10 42.86
2017-11-07 13F-HR AMERIPRISE FINANCIAL INC 14,500 14,500 0.00 6 10 66.67
2017-10-17 13F-HR Creative Planning 146,699 13,400 -90.87 63 9 -85.71
2017-11-09 13F-HR JP MORGAN CHASE & CO 2,300 2,300 0.00 1 2 100.00
2017-11-14 13F-HR MORGAN STANLEY 100 100 0.00 0 0
2017-10-25 13F-HR FIRST MANHATTAN CO 50 50 0.00 0 0
2017-11-09 13F-HR WELLS FARGO & COMPANY/MN 200 200 0.00 0 0
2017-08-11 13F-HR KCG HOLDINGS, INC. 161,073 31,267 -80.59 53 13 -75.47
2017-11-14 13F-HR ROYAL BANK OF CANADA 174,100 174,042 -0.03 75 115 53.33
2017-11-09 13F-HR CITADEL ADVISORS LLC 0 58,936 0 39
2017-10-13 13F-HR ACADIAN ASSET MANAGEMENT LLC 335,421 223
2017-11-15 13F-HR Highlander Capital Management, LLC 50,000 50,000 0.00 22 33 50.00
2017-11-08 13F-HR MACQUARIE GROUP LTD 72,556 48
2017-11-17 13F-HR/A-1 Virtu Financial LLC 337,947 224
2017-11-07 13F-HR BANQUE PICTET & CIE SA 62,000 62,000 0.00 27 41 51.85
2017-11-13 13F-HR Shepherd Financial Partners LLC 25,784 0 -100.00 11 0 -100.00
2017-11-13 13F-HR INVESTMENT CENTERS OF AMERICA INC 24,500 23,000 -6.12 11 15 36.36
2017-11-06 13F-HR Bank of New York Mellon Corp 25,237 151,473 500.20 11 101 818.18

Stock Research Report

Palatin Technologie is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its lead product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder (“HSDD”), which is a type of female sexual dysfunction (“FSD”), defined as low desire with associated distress. In addition, Palatin has drug candidates and development programs for cardiovascular diseases and inflammatory diseases.

The following drug development programs are actively under development:

  • Bremelanotide, an as-needed subcutaneous injectable product for the treatment of HSDD in premenopausal women. Bremelanotide is a synthetic peptide analog of the naturally occurring hormone alpha-MSH (melanocyte-stimulat...
Click for full article
CUSIP: 696077403